Email:
sales@chinesepeptide.com
Sep 11, 2023
In addition, CPC specializes in the production of generic peptides on an industrial scale, following the CGMP's (Current Good Manufacturing Practices). Our expertise allows us to manufacture a range of high-quality generic peptides at a commercial scale. With stringent quality control measures in place, we ensure consistent and reliable production of generic peptides that meet regulatory standards.
Our Generic API Portfolio:
| API Name | Indications | DMF Schedule | |
| Tumour | Leuprorelin Acetate | Prostate & Breast Cancer;Endometriosis; Uterine Leiomyomata;Precocious Puberty. | MFDS: 20200625-210-J-661 NMPA: Y20190007496(A) |
| Triptorelin Acetate | Prostate & Breast Cancer; Endometriosis; Uterine Leiomyomata;Assisted Reproduction. | NMPA: Y20170001090(A) MFDS: TBD | |
| Triptorelin Pamoate | Endometriosis; Uterine Fibroids; Premature Puberty; Prostate Cancer;ART. | NMPA: Y20200001405 | |
| Goserelin Acetate | Suppress production of the sex hormones | NMPA: 2023/Q2 | |
| Lanreotide | Acromegaly;GEP-NETs and Carcinoid Syndrome; | NMPA: TBD | |
| Procreation | Cetrorelix Acetate | In Vitro Fertilization (IVF). | NMPA: Y20190001147(A) FDA: 034884 |
| Ganirelix Acetate | To inhibit premature LH surges during controlledovarian hyper-stimulation. | NMPA: TBD | |
| Diabetes | Exenatide Acetate | Exenatide is an injectable diabetes medicine that helps control blood sugar levels. This medication helpspancreas produce insulin more effciently. | NMPA: 2015/1 NMPA: Y20170001378 |
| Semaglutide | Type ll diabetes. | NMPA: TBD | |
| Gastrointestinal | Terlipressin Acetate | An analogue of vasopressin, prescribed for bleedingesophageal varices, septic shock, hepatorenal syndrome and in management of low blood pressure | CEP:2020-111 NMPA: Y20200000281(A) |
| Teduglutide | A prescription medicine for adults with Short BowelSyndrome who need additional nutrition or fluids fromIV feeding. | NMPA: TBD | |
| Linaclotide | lrritable Bowel Syndrome with Constipation (IBS-C):Chronic ldiopathic Constipation (CIC) | NMPA: Y20210000906 | |
| Plecanatide | Chronic ldiopathic Constipation (CIC) | NMPA: TBD | |
| Other | Difelikefalin | Treatment of moderate-to-severe pruritus associated with chronic kidney disease(CKD-aP; uremic pruritus) in adults undergoing hemodialysis. | NMPA: TBD |
Please submit a detailed description of your request. We will provide you with professional services to meet your research requests. You can also send emails directly to sales@chinesepeptide.com for inquiries.
